MétaCan
Menu
← Back to cohort
Record W4205665355 · doi:10.2196/preprints.36163

Title of the article: Omicron, a new variant of SARS COV-2 and impact of immunization on it---all that we know so farAbstract:- Introduction:-The latest variant of SARS COV-2 has been identified in South Africa for the first time and was subsequently reported to World Health Organization on 24th November 2021.A couple of days later WHO has named this variant as Omicron as well as declared it as a Variant of Concern(VoC).This variant evolved during a crucial phase of the current Pandemic, when the vaccination-induced immunity development has been kept as a topmost priority to combat the current scenario. Areas Covered:- Approximately fifty genomic mutations have rendered this variant as a more transmissible var (Preprint)

2022· preprint· en· W4205665355 on OpenAlexaboutno aff
Dr Shouvik Choudhury

Bibliographic record

Venuenot available
Typepreprint
Languageen
FieldSocial Sciences
TopicVaccine Coverage and Hesitancy
Canadian institutionsnot available
Fundersnot available
KeywordsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)ImmunizationVirologyBiologyMedicineGeneticsDiseaseInfectious disease (medical specialty)AntibodyPathology

Abstract

fetched live from OpenAlex

BACKGROUND B.1.1.529 variant was first discovered in Botswana on November 11, 2021, and in South Africa on November 14, 2021.On November 26, 2021, the World Health Organization (WHO) identified lineage B.1.1.529 of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) as a Variant of Concern (VOC) [1]The United Kingdom Health Security Agency identified B.1.1.529 as a Variant Under Monitoring (VUI21-NOV-01) on November 25, 2021.[2] The Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) met on November 26, 2021, to examine B.1.1.529.[3] The TAG-VE recommended that this variant to be identified as a Variant of Concern (VOC). The WHO called it after omicron, the fifteenth letter in the Greek alphabet.[4,5] Although earlier VoCs appeared in a world where natural immunity to COVID-19 infections was frequent, this fifth VoC appears at a time when vaccination-induced immunity is developing globally .The first incidence of B.1.1.529 was reported in the United States on December 1, 2021, in a person returning from a trip t South Africa. On December 2, 2021, a second case was reported in an individual with no prior overseas travel history who similarly attended a convention. In addition to Europe, the Omicron variation has been found in instances involving travel in Australia, Brazil, Canada, Hong Kong, Israel, Japan, Nigeria, Norway, Sweden, United Kingdom and India. OBJECTIVE Genomic features:-Although clear immunological and clinical evidence is still lacking, few information are available regarding its transmissibility, mutation and escape from immunity. Omicron has approximately 50 mutations in its genome, including 32 mutations in the spike protein.[6]. The spike protein contains the following mutations: A67V, 69-70, T95I, G142D/143-145, 211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y.[7,8]Three alterations ( H655Y, N679K , P681H) near the furin cleavage site may improve transmissibility and replication.[9] Six mutations in the N-terminal region have been linked to innate, vaccine-based, or monoclonal antibody neutralization.T478K (also discovered in Delta), N501Y (also found in Alpha, Beta, and Gamma), and Q498R (not previously found in VOCs) alterations in the receptor-binding domain may improve the virus's affinity for ACE2 receptors on host cells.[10,11] and encourage the development of immunological escape mechanisms.The nsp6 deletion 105-107 (also observed in Alpha, Beta, and Gamma VOCs) may be linked to additional evasion of innate immunity and increased transmissibility outside of the spike protein.[12]R203K and G204R nucleocapsid alterations (also identified in Alpha and Gamma VOCs) may be linked to higher infectivity.[13] In comparison to the original Wuhan variety, the Omicron variant has 60 mutations: 50 nonsynonymous mutations, 8 synonymous mutations, and 2 non-coding mutations.[14]At least one new mutation may have been acquired from one of the coronaviruses that causes the common cold (HCoV-229E) or the human immunodeficiency virus (HIV), since that particular genetic sequence is known to exist in both of these viruses; South Africa likewise has the world's highest incidence of HIV infection, creating a high likelihood of concurrent infection.[15] METHODS Why Variant of Concern (VoC) ??--The WHO classified Omicron as a VOC based on epidemiological evidences that showed a surge in illnesses in South Africa in recent weeks, coinciding with Omicron detection.The US Department of Health and Human Services formed the SARS-CoV-2 Interagency Group (SIG), which is in charge of variant classifications in the US. The SIG meets on a regular basis to assess the risk posed by SARS-CoV-2 variants circulating in the United States and around the world, as well as to offer suggestions on variant classification. The SIG decided to identify the Omicron version as a Variant of Concern on November 30, 2021. (VOC). This decision is based on a number of factors, including the detection of Omicron-related cases in multiple countries, including among those with no prior travel history, transmission and replacement of Delta as the predominant variant in South Africa, the number and locations of substitutions in the spike protein, and available data for other variants with fewer substitutions in the spike protein, indicating a reduction in neutralization by vaccine and convalescent sera.In South Africa, the average number of COVID-19 cases per day jumped from 280 cases per day the week before omicron was discovered to 800 cases per day the following week, owing in part to greater surveillance. COVID-19 cases are rapidly increasing in South Africa's Gauteng area; the fourth wave's early doubling time is faster than the prior three waves.[16] RESULTS Disease Transmissibility:-It is yet unknown how quickly the Omicron variant can transmit from one person to another. The replacement of Delta by Omicron as the most common variant in South Africa has raised concerns that the Omicron variant is more transmissible than Delta. However, due to the small number of cases in South Africa when Omicron first appeared, it is unclear whether this variant is more transmissible than Delta. Furthermore, estimating transmissibility is problematic due to the small number of cases described to date. The differences in the spike protein suggest that the Omicron variety is more transmissible than the original SARS-CoV-2 virus, but it's difficult to say if it's more transmissible than Delta. N501Y increases ACE2 receptor binding, which may improve transmission, and the combination of N501Y and Q498R may boost binding even more; nevertheless, other Omicron spike protein changes are expected to diminish ACE2 receptor binding. As a result, the whole range of spike protein changes present in the Omicron variation must be used to measure receptor binding affinity. Because H655Y is close to the furin cleavage point, it may accelerate spike cleavage, aiding transmission. N679K is close to the furin cleavage site and contributes to its polybasic character, which may enhance spike cleavage and help transmission. Spike cleavage has been observed to be enhanced by P681H, which could assist transmission. This mutation is found in Alpha, but a different mutation (P681R) is found in Delta.Omicron's effect on transmissibility is a matter of serious concern. Higher transmissibility is expected if the overlapping omicron mutations maintain their known effects, especially because of mutations near the furin cleavage site. Early epidemiological evidence suggests that instances are increasing in South Africa, as PCR tests fail to target the S-gene. However, preliminary evidence suggests that it is spreading rapidly against a backdrop of continued delta-variant transmission and high natural immunity to the delta variation. If current trends continue, omicron is expected to supplant delta as the most common variation in South Africa. R is the average number of new cases created by each infection and it is used by epidemiologists to track the spread of an epidemic.R, the average number of new cases created by each infection.[17]According to Tom Wenseleers, an evolutionary biologist at the Catholic University of Leuven in Belgium, Gauteng's R value was well below 1 in September, when Delta was the predominant variant and cases were falling, indicating that Omicron has the potential to spread much faster and infect far more people than Delta.The R in South Africa was expected to have climbed to 3 percent on November 26, 2021, across all provinces.[18] Immune Escape:-Another issue to consider is immune escape. Preliminary findings from the nationwide PCR testing programme could provide some clues in the absence of data on observational vaccination effectiveness and antibody-neutralisation tests on vaccinee sera. Positive PCR tests among patients who had previously tested positive suggest an increase in cases of reinfection in South Africa. However, the increased use of fast antigen testing, as well as the incomplete recording of negative results, have made it more difficult to interpret test positivity rates, which have climbed to nearly four times the prior rate in the last week. Despite this limitation, the rise in reinfection instances is consistent with the immune-escape alterations found in omicron. Disease Severity:-It is still unknown if infection with the Omicron form causes more severe disease.According to preliminary data from South Africa, there are no special symptoms linked with Omicron variant infection, and some patients are asymptomatic, as with other variants.[19]As of November 2021, it is unknown how the variant will spread in immune-compromised populations, or whether the omicron variant causes a milder or more severe COVID-19 infection.[20]At this time, anecdotal data from South African medics working on the front lines suggests that patients with omicron are younger persons with a clinical presentation comparable to that of previous variations. Although more nations are identifying the Omicron variety, affluent countries have the capacity to quickly sequence viruses from positive COVID-19 testing, skewing early statistics on Omicron's distribution.The South African Medical Research Council reported on 4 December that inpatients at a hospital complex in Tshwane were younger than in previous waves from 14 to 29 November 2021, and ICU and oxygen therapy rates were lower than in previous waves. These findings are not c

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Direct model labels (unvalidated)

Per-model category and study-design labels from the labeling rounds. They are machine output, unvalidated, and the disagreement between models ships as data. No study design here is MEDLINE-validated yet.

Model armCategoriesStudy designConfidence
gemmano category
Domain: not available · Genre: Review
About the Canadian research system: no · About a Canadian topic: no
Not applicablelow
gptno category
Domain: not available · Genre: Review
About the Canadian research system: no · About a Canadian topic: no
Other designlow
models splitAgreement compares identical category sets and study designs across arms.

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.042
Threshold uncertainty score0.141

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0010.001
Scholarly communication0.0020.001
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0420.021

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.085
GPT teacher head0.339
Teacher spread0.254 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Labeled directly by 2 models reading the full record.

The models applied no category: nothing in the taxonomy fit this work.

The models disagree on parts of this classification; every voice is preserved in the section at the end of the page.

Study designNot applicable · Other design
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes1
Has abstractyes

Explore more

Same topicVaccine Coverage and Hesitancy→French-language works237,207→